Volitionrx (VNRX) Shares Outstanding (Weighted Average) (2011 - 2025)

Volitionrx (VNRX) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $36.3 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 40.5% year-over-year to $36.3 million; the trailing twelve-month figure through Dec 2025 stood at $36.3 million (up 40.5% YoY), and the FY2025 full-year result was $36.3 million, up 40.5% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $36.3 million, down from $48.0 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $87.9 million in Q3 2024 and bottomed at $539000.0 in Q4 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $52.8 million (2021), against an average of $51.3 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) plunged 98.98%; it then surged 2895.52% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $52.7 million in 2021, then slumped by 98.98% to $539000.0 in 2022, then jumped by 60.02% to $862500.0 in 2023, then soared by 2895.52% to $25.8 million in 2024, then soared by 40.5% to $36.3 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $36.3 million (Q4 2025), $48.0 million (Q3 2025), and $47.3 million (Q2 2025), per Business Quant data.

Peer Comparison